News
Video
Compounded GLP-1 RA drugs: What about prices? Are compounded drugs cheaper or more expensive than manufacturers’ versions?
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
GLP-1 RA drugs have made headlines for improving health — and for high costs. Compounded versions may be less expensive, but that is not the case with every drug. Scott Brunner, CAE, CEO of the Alliance for Pharmacy Compounding, explains the context of cost for compounded medicines.
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.
Related Videos
Related Content
